You just read:

Aeterna Zentaris and Yakult Honsha Sign a Development, Commercialization and Licensing Agreement for Lead Oncology Compound, Perifosine, for the Japanese Market

News provided by

AETERNA ZENTARIS INC.

Mar 09, 2011, 02:00 EST